Clear Harbor Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.22 Billion
- Q3 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 17,550 shares of IOVA stock, worth $131,449. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,550
Previous 30,800
43.02%
Holding current value
$131,449
Previous $247,000
33.6%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$205 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$199 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$180 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$98.9 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.18B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...